Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026)

Ascendis Pharma A has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.62 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 158.25% year-over-year to 0.62 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62 (up 158.25% YoY) and the FY2025 annual result came in at 0.34, up 68.62% from the prior year.
• Asset Utilization Ratio eased to 0.62 in Q1 2026 per ASND's latest filing, from 0.71 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.71 in Q4 2025 and troughed at 0.04 in Q4 2022.
• A 5-year average of 0.35 and a median of 0.24 in 2025 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 1044.42% in 2023, then plunged 60.25% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.04 in 2022, then jumped by 1044.42% to 0.51 in 2023, then plunged by 53.46% to 0.24 in 2024, then jumped by 201.82% to 0.71 in 2025, then declined by 12.49% to 0.62 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.62, 0.71, and 0.67 for Q1 2026, Q4 2025, and Q3 2025 respectively.